A systematic protocol for the characterization of Hsp90 modulators
- 1 January 2011
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 19 (1) , 684-692
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (HD055763, CA109265, CA125392)
- Madison and Lila Self Graduate Fellowship
- American Foundation for Pharmaceutical Education
This publication has 48 references indexed in Scilit:
- Molecular Mechanism of Inhibition of the Human Protein Complex Hsp90–Cdc37, a Kinome Chaperone–Cochaperone, by Triterpene CelastrolAngewandte Chemie International Edition, 2009
- To Fold or Not to Fold: Modulation and Consequences of Hsp90 InhibitionFuture Medicinal Chemistry, 2009
- The Design, Synthesis, and Evaluation of Coumarin Ring Derivatives of the Novobiocin Scaffold that Exhibit Antiproliferative ActivityThe Journal of Organic Chemistry, 2008
- Silencing the cochaperone CDC37 destabilizes kinase clients and sensitizes cancer cells to HSP90 inhibitorsOncogene, 2008
- A novel Hsp90 inhibitor to disrupt Hsp90/Cdc37 complex against pancreatic cancer cellsMolecular Cancer Therapeutics, 2008
- A non-toxic Hsp90 inhibitor protects neurons from Aβ-induced toxicityBioorganic & Medicinal Chemistry Letters, 2007
- Novobiocin: Redesigning a DNA Gyrase Inhibitor for Selective Inhibition of Hsp90Journal of the American Chemical Society, 2006
- The Connectivity Map: Using Gene-Expression Signatures to Connect Small Molecules, Genes, and DiseaseScience, 2006
- Structure and Mechanism of the Hsp90 Molecular Chaperone MachineryAnnual Review of Biochemistry, 2006
- Hsp90 Inhibitors Identified from a Library of Novobiocin AnaloguesJournal of the American Chemical Society, 2005